Evidence map›Paper›PMID 39123453›Full record

ArticleCancers2024

Kaniz Fatema, Yanliang Wang, Adriene Pavek, Zachary Larson, Christopher Nartker, Shawn Plyler, Amanda Jeppesen, Breanna Mehling, Mario R Capecchi, Kevin B Jones and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. ARID1A and Its Impact Across the Hallmarks of Cancer.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kaniz FatemaDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.ORCID 0009-0002-8552-2846
Yanliang WangDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Adriene PavekDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
Zachary LarsonDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
Christopher NartkerDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
Shawn PlylerDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
Amanda JeppesenDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
Breanna MehlingDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.
Mario R CapecchiDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Kevin B JonesDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Jared J BarrottDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA.ORCID 0000-0001-6059-9009

Funding

Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Kenneth A Cornell · 2012 to 2026
$59.8M
Targeting SS18-SSX biology in synovial sarcomagenesisU54CA231652 · NCI · UNIVERSITY OF UTAH · PI JONES, KEVIN BRUCE · 2018 to 2022
$12.0M
Epigenetic Mechanisms Driving Synovial SarcomagenesisR01CA201396 · NCI · UNIVERSITY OF UTAH · PI CAIRNS, BRADLEY R., JONES, KEVIN BRUCE · 2017 to 2021
$1.7M
CSRD VA 1NCI NIH HHS R01 CA201396NCI NIH HHS U54 CA231652NIGMS NIH HHS P20 GM103408NIH HHS P20 GM103408NIH HHS R01CA201396NIH HHS U54CA231652State of Idaho CPI
6 · The paper itself

Abstract

Osteosarcoma is an aggressive bone malignancy, molecularly characterized by acquired genome complexity and frequent loss of

Indexed as

Arid1aDNA damage repairDSBepigeneticsforward genetic screengenomic instabilityosteosarcomapiggyBacSSBSWI/SNF

Identifiers

PMID39123453
PMCPMC11311538

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.